GlassScriptPhysician profile
Thomas J Kunz
NPI 1558642769
$1,279.59
in general payments reported to CMS, 2019-2025
16 companies · $54.00 in 2025
The $54.00 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $82.19 · 2021: $225 · 2022: $248 · 2023: $164 · 2024: $198 · 2025: $54.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403 · Entertainment: $13.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.33 |
| Entertainment | $13.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $307.50 | 2019-2025 | Precision 1, Dailies, Total30 |
| Aerie Pharmaceuticals, INC. | $163.17 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $126.13 | 2019-2021 | |
| Biotissue Holdings INC. | $105.49 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $97.91 | 2019-2025 | |
| Glaukos Corporation | $94.22 | 2022 | |
| Dompe US, INC. | $72.52 | 2022-2024 | Oxervate |
| Bausch & Lomb Americas INC. | $71.62 | 2022-2024 | Miebo, Vyzulta, Biotrue One Day |
| Abb Con-Cise Optical Group LLC | $61.42 | 2019 | |
| Allergan, INC. | $41.87 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $40.43 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $31.63 | 2023-2024 | Tyrvaya |
| Abbvie INC. | $29.52 | 2022 | |
| Optos, INC. | $13.03 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $11.91 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kunz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.